Aethlon Medical CEO Named To Biodefense Panel At The 2006 Homeland And Global Security Summit

SAN DIEGO--(BUSINESS WIRE)--April 5, 2006--Aethlon Medical, Inc. (OTCBB:AEMD - News), a pioneer in developing therapeutic devices for infectious disease, announced today that its Chairman and CEO, James A. Joyce has been named to the Biodefense Priorities, Programs, and Funding Panel at the 2006 Homeland and Global Security Summit. The Summit is being held on April 11 at the Washington Convention Center in Washington, D.C. The other panel members are: